Therapeutic Class (Cardiology):

Anti-inflammatory agent



MYINFLA is supplied in bottles of 100 tablets.



Medicinal ingredients: Colchicine

Non-medicinal ingredients: Ammonio methacrylate copolymer, FD&C Blue #1, glyceryl monostearate, invert sugar syrup, iron oxide yellow, magnesium stearate, maltodextrin, polyethylene glycol, polyvinyl alcohol-part hydrolyzed, polysorbate 80, povidone, sodium starch glycolate, sucrose, talc, titanium dioxide, triethyl citrate, water.



MYINFLA (colchicine extended-release tablets) is indicated for the reduction of atherothrombotic events in adult patients with existing coronary artery disease, in addition to standard therapies, including LDL-C lowering and antithrombotic drug treatment.


Directions for Use:

Recommended Dose and Dosage Adjustment:

MYINFLA is to be administered orally as a single 0.5 mg tablet once daily. The maximum dose is 0.5 mg daily



MYINFLA may be administered with or without food. Avoid taking grapefruit juice, a moderate CYP3A4 inhibitor, with MYINFLA



MYINFLA is contraindicated:

  • with strong P-glycoprotein (P-gp) inhibitors or strong CYP3A4 inhibitors
  • in severe renal impairment (eGFR < 30 mL/min)
  • in severe hepatic impairment
  • in patients with existing blood dyscrasias, and
  • in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.


Storage: 15°C – 30°C. Keep out of sight and reach of children. Do not use if inner seal of bottle is broken or missing.


MyInflaTM is a trademark of Pharmascience Inc.


These products may not be suitable for everyone. Read the labels and follow the directions of use. For additional information, contact us at 1-888-550-6060 or by email at